4D Molecular Therapeutics Appoints Kristian Humer as Chief Financial Officer
Position
Chief Financial Officer
Company
4D Molecular Therapeutics
EmeryvilleBiotechnologyHealth CareMedicalGeneticsTherapeuticsDescription
4D Molecular Therapeutics has announced the appointment of Kristian Humer as Chief Financial Officer, effective immediately. With over 20 years of experience in corporate finance and biotechnology, Humer will oversee the company's financial strategies during a critical transitional phase.
Quick answer
4D Molecular Therapeutics Appoints Kristian Humer as Chief Financial Officer (November 17, 2025). 4D Molecular Therapeutics is based in Emeryville, California, United States.
- Who is the new Chief Financial Officer at 4D Molecular Therapeutics?
- 4D Molecular Therapeutics named Kristian Humer Chief Financial Officer, announced November 17, 2025.
- What did 4D Molecular Therapeutics announce on November 17, 2025?
- 4D Molecular Therapeutics has announced the appointment of Kristian Humer as Chief Financial Officer, effective immediately. With over 20 years of experience in corporate finance and biotechnology, Humer will oversee the company's financial strategies during a critical transitional phase.
- What does 4D Molecular Therapeutics do?
- 4DMT is a late-stage biotechnology company developing durable, disease-targeted genetic medicines designed to transform treatment paradigms and deliver long-lasting benefits to patients.
- Where is 4D Molecular Therapeutics based?
- 4D Molecular Therapeutics is based in Emeryville, California, United States.
- Which similar companies made leadership changes around the same time?
- OncoNano Medicine (November 17, 2025), Celldex (November 11, 2025), Novocure (December 1, 2025) and Prime Medicine (November 3, 2025) also announced leadership changes within 45 days of 4D Molecular Therapeutics.
Source: Fundz verified event record.
Other recent leadership changes in Medical and Genetics
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- OncoNano Appoints Brent Sorrells as Chief Operating Officer (November 17, 2025)
- Celldex Therapeutics Appoints Teri Lawver as Chief Commercial Officer (November 11, 2025)
- Novocure Appoints Frank Leonard as Chief Executive Officer (December 1, 2025)
- Prime Medicine Appoints Matthew Hawryluk as Chief Business Officer (November 3, 2025)
- RetinalGenix Technologies Inc. Appoints M. Cory Zwerling as Interim Chief Operating Officer (December 9, 2025)
- Pliant Therapeutics Appoints Minnie Kuo as Chief Operating Officer (December 16, 2025)
Who to call at 4D Molecular Therapeutics, and when
A new leader at 4D Molecular Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day 4D Molecular Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at 4D Molecular Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at 4D Molecular Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment 4D Molecular Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
4D Molecular Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.